Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

PPARdelta is a ligand-dependent negative regulator of vitamin D3-induced monocyte differentiation.

Lymboussaki A, Gemelli C, Testa A, Facchini G, Ferrari F, Mavilio F, Grande A.

Carcinogenesis. 2009 Feb;30(2):230-7. doi: 10.1093/carcin/bgn272. Epub 2008 Dec 4.

PMID:
19056929
2.

The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression.

Lymboussaki A, Pignatti E, Montosi G, Garuti C, Haile DJ, Pietrangelo A.

J Hepatol. 2003 Nov;39(5):710-5.

PMID:
14568251
3.

Growth factors regulating lymphatic vessels.

Lymboussaki A, Achen MG, Stacker SA, Alitalo K.

Curr Top Microbiol Immunol. 2000;251:75-82. No abstract available.

PMID:
11036761
4.

Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation.

Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK.

Cancer Res. 2000 Aug 15;60(16):4324-7.

5.
6.

Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature.

Aase K, Lymboussaki A, Kaipainen A, Olofsson B, Alitalo K, Eriksson U.

Dev Dyn. 1999 May;215(1):12-25.

7.

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3.

Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K.

Science. 1998 Oct 30;282(5390):946-9.

8.

Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.

Lymboussaki A, Partanen TA, Olofsson B, Thomas-Crusells J, Fletcher CD, de Waal RM, Kaipainen A, Alitalo K.

Am J Pathol. 1998 Aug;153(2):395-403.

9.

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors.

Salven P, Lymboussaki A, Heikkilä P, Jääskela-Saari H, Enholm B, Aase K, von Euler G, Eriksson U, Alitalo K, Joensuu H.

Am J Pathol. 1998 Jul;153(1):103-8.

10.

Bmx tyrosine kinase is specifically expressed in the endocardium and the endothelium of large arteries.

Ekman N, Lymboussaki A, Västrik I, Sarvas K, Kaipainen A, Alitalo K.

Circulation. 1997 Sep 16;96(6):1729-32.

PMID:
9323053
11.

Expression of vascular endothelial growth factor and placenta growth factor in human placenta.

Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, Halmesmäki E.

Biol Reprod. 1997 Feb;56(2):489-94.

PMID:
9116151
12.

VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.

Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K.

Development. 1996 Dec;122(12):3829-37.

13.

Expression of Mad, an antagonist of Myc oncoprotein function, in differentiating keratinocytes during tumorigenesis of the skin.

Lymboussaki A, Kaipainen A, Hatva E, Västrik I, Jeskanen L, Jalkanen M, Werner S, Stenbäck F, Alitalo R.

Br J Cancer. 1996 Jun;73(11):1347-55.

Supplemental Content

Loading ...
Support Center